Explore ›
Finding
Finding
adverse
Among women without baseline dyspareunia (n=134), 6%, 5%, and 10% reported de novo dyspareunia at 6, 12, and 24 months respectively. Only 3 of 19 affected women received treatment by 24 months, and none required surgery.
| Effect size | 10% de novo dyspareunia at 24 months |
| Follow-up | 24 months |
| Comparator | Pre-operative baseline (women without dyspareunia at baseline) |
| Effect summary | adverse; 10% de novo dyspareunia at 24 months |
| Adverse events | de novo dyspareunia 10% at 24 months |
Connected entities
Interventions
Outcomes
Populations
Source
PMC4879084
Quality of Life and Sexual Function 2 Years After Vaginal Surgery for Prolapse